Developmental Research Program (DRP)
Developmental Research Program (DRP)
批准号:
10469378
负责人:
URSULA Anne MATULONIS
金额:
$29.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-03 至 2025-07-31
关键词:
AdvocateAttentionAwardBudgetsCancer CenterComplementDevelopmentDiagnosisEarly DiagnosisEnsureEquilibriumEvaluationFacultyFosteringFundingGoalsGrantInstitutionMalignant neoplasm of ovaryMentorsMentorshipMethodsMinorityMinority WomenMissionMonitorPilot ProjectsPreventionProcessProductivityProgram Research Project GrantsProgress ReportsRequest for ApplicationsResearchResearch ActivityResearch PersonnelResistanceResourcesSpecific qualifier valueTimeLineTranslational ResearchWomanbasecommunity centerhigh riskinnovationnovelprogramsresearch and developmentsoundsuccesstranslational potential
中文摘要
项目摘要/摘要-发展研究计划研究计划
达纳-法伯/哈佛癌症中心(DF/HCC)卵巢癌孢子的总体目标
发展研究计划(DRP)旨在支持高风险/高潜力的试点项目
在DF/HCC卵巢癌孢子内最大限度地利用新的研究机会
在整个资助期内维持本计划。遴选和监测过程将由
DRP主任Ursula Matulonis博士、Stephen Cannstra和Alan D‘Andrea,由另一人监督
孢子领袖斯普里格斯博士。DF/HCC卵巢癌DRP执行委员会(EC),即
由DF/HCC孢子委员会、外部咨询委员会、内部咨询委员会(IAB)组成
而本次卵巢癌孢子计划的卵巢癌倡导者核心将直接参与
DRP项目的评审、评分和选择。DRP将鼓励少数族裔和
妇女以及高风险/高回报项目。全面获取DF/HCC卵巢癌孢子资源
包括核心访问权限将可用于DRP项目。那些已经证明很棒的项目
进展和翻译研究潜力将有可能成为完整的孢子项目,但只有
经DF/HCC卵巢癌DRP EC批准。DRP的资金部分来自
卵巢癌孢子预算以及来自DF/HCC机构的大量资金。
英文摘要
PROJECT SUMMARY/ABSTRACT - DEVELOPMENTAL RESEARCH PROGRAM RESEARCH PLAN
The overall goals of the Dana-Farber/Harvard Cancer Center (DF/HCC) Ovarian Cancer SPORE
Developmental Research Program (DRP) are to support high risk/high potential pilot projects that take
maximum advantage of new research opportunities within the DF/HCC Ovarian Cancer SPORE and to
maintain this Program throughout the entire grant term. The selection and monitoring process will be led by
the DRP Directors, Drs. Ursula Matulonis, Stephen Cannistra and Alan D’Andrea, with oversight from the other
SPORE leader, Dr. Spriggs. The DF/HCC Ovarian Cancer DRP Executive Committee (EC) which is
comprised on the DF/HCC SPORE committee, the External Advisory Board, the Internal Advisory Board (IAB)
and the Ovarian Cancer Advocate Core of this Ovarian Cancer SPORE Project will directly participate in the
review, scoring and selection of DRP Projects. The DRP will encourage applications from minorities and
women as well as high risk/high payoff projects. Full access to DF/HCC Ovarian Cancer SPORE resources
including Core access will be available to DRP Projects. Those projects that have demonstrated great
progress and translational research potential will have the potential to become full SPORE Projects but only
with the approval of the DF/HCC Ovarian Cancer DRP EC. Funding for the DRP is comprised partly from the
Ovarian Cancer SPORE budget as well as significantly from DF/HCC institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10024420
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10684241
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10228055
-
项目类别:
-
资助金额:$15.18万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10228054
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10684234
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
-
批准号:10469377
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Developmental Research Program (DRP)
-
批准号:10024421
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2020
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Program 02: Gynecologic Cancers
-
批准号:10332564
-
项目类别:
-
资助金额:$4.2万
-
财政年份:1997
-
负责人:URSULA Anne MATULONIS
-
依托单位:
Program 02: Gynecologic Cancers
-
批准号:10540423
-
项目类别:
-
资助金额:$4.2万
-
财政年份:1997
-
负责人:URSULA Anne MATULONIS
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位:
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:82202156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位: